Cite
Evolution of resistance to a tricyclic pyrimidoindole DNA gyrase/topoisomerase inhibitor in Escherichia coli and Acinetobacter baumannii is driven by upregulation of efflux machinery (Updated June 28, 2023).
MLA
“Evolution of Resistance to a Tricyclic Pyrimidoindole DNA Gyrase/Topoisomerase Inhibitor in Escherichia Coli and Acinetobacter Baumannii Is Driven by Upregulation of Efflux Machinery (Updated June 28, 2023).” Drug Week, July 2023, p. 434. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=164758572&authtype=sso&custid=ns315887.
APA
Evolution of resistance to a tricyclic pyrimidoindole DNA gyrase/topoisomerase inhibitor in Escherichia coli and Acinetobacter baumannii is driven by upregulation of efflux machinery (Updated June 28, 2023). (2023). Drug Week, 434.
Chicago
“Evolution of Resistance to a Tricyclic Pyrimidoindole DNA Gyrase/Topoisomerase Inhibitor in Escherichia Coli and Acinetobacter Baumannii Is Driven by Upregulation of Efflux Machinery (Updated June 28, 2023).” 2023. Drug Week, July, 434. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=164758572&authtype=sso&custid=ns315887.